You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
5 March 2026 - Digital therapeutics developer GAIA and Daiichi Sankyo Europe, part of Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568), on Thursday announced an exclusive strategic partnership to commercialise the digital therapeutic lipo...
5 March 2026 - Chinese biopharmaceutical company Akeso Inc (HK:9926) announced on Wednesday that it has agreed a clinical trial collaboration and supply agreement with INOVIO (NASDAQ:INO), a US-based biotechnology company focused on developing and co...
5 March 2026 - Airiver Medical, a clinical stage company developing technologies to help patients who suffer from certain respiratory tract conditions, announced on Wednesday that it has received Breakthrough Device Designation from the US Food and D...
4 March 2026 - Biotechnology company Allergy Therapeutics plc (AIM: AGY) on Wednesday reported positive biomarker results from its Phase I/IIa PROTECT trial of VLP Peanut, following the achievement of the study's primary safety endpoint.The tria...
4 March 2026 - Chinese biotechnology company Sino Biological Inc (SZ:301047) announced on Wednesday that it has launched the 2026-2027 Northern Hemisphere influenza vaccine strain antigens to accelerate vaccine development.This follows the World Heal...
3 March 2026 - US commercial stage biopharmaceutical company Esperion Therapeutics Inc (NASDAQ:ESPR) on Tuesday announced a definitive agreement to acquire privately held Corstasis Therapeutics Inc, adding Enbumyst (bumetanide nasal spray) to its car...
3 March 2026 - Breckenridge Pharmaceutical Inc, the US subsidiary of Spain-based Towa International, announced on Monday the launch of Pomalidomide Capsules, a generic version of Pomalyst by Celgene (now Bristol Myers Squibb), within the oncology the...